Improve walking through transcranial stimulation

Trial ID
NCT07182058
Official Title
Virtual Remote Assessment of Transcranial Electrical Stimulation for Parkinson's Disease Motor Symptoms
Goal
Improve walking through transcranial stimulation
Phase
PHASE1, PHASE2
Status
RECRUITING
Sponsor
U: The Mind Company
Study Type
INTERVENTIONAL
Enrollment
30 participants
Conditions
PARKINSON DISEASE (Disorder)
Interventions
Transcranial Electrical Stimulation Device

Summary For Families

It aims to ease motor symptoms like tremor, slowness, and stiffness by testing whether remotely delivered transcranial electrical stimulation can safely improve movement in people with Parkinson's. The device sends gentle, low-level electrical currents through the scalp to tweak the excitability of motor brain circuits, sessions are done at home with telehealth supervision, and it is studied as an add-on rather than a replacement for levodopa or other Parkinson's medications so participants need a stable regimen. Looking for adults 18 to 80 with Parkinson's at Hoehn and Yahr stages 1 to 4 who have stable meds and reliable internet; people with metal head or neck implants, a history of seizures, recent stroke, pregnancy, severe cognitive impairment, serious skin problems at electrode sites, or current participation in other trials are excluded.

Locations

  • U LLC Headquarters, Cleveland, Ohio, United States

Frequently Asked Questions

What is this trial testing?
This trial is studying Transcranial Electrical Stimulation Device. It aims to ease motor symptoms like tremor, slowness, and stiffness by testing whether remotely delivered transcranial electrical stimulation can safely improve movement in people with Parkinson's. The device sends gentle, low-level electrical currents through the scalp to tweak the excitability of motor brain circuits, sessions are done at home with telehealth supervision, and it is studied as an add-on rather than a replacement for levodopa or other Parkinson's medications so participants need a stable regimen. Looking for adults 18 to 80 with Parkinson's at Hoehn and Yahr stages 1 to 4 who have stable meds and reliable internet; people with metal head or neck implants, a history of seizures, recent stroke, pregnancy, severe cognitive impairment, serious skin problems at electrode sites, or current participation in other trials are excluded.
Who can participate?
Participants must be between 18 Years and 80 Years.
Where is this trial located?
This trial is recruiting at 1 location.
Does it cost anything to join?
No. There is no cost to participate. Study-related care and treatment are provided at no charge.
How long does the trial last?
This Phase 1/Phase 2 trial is estimated to last approximately 2 months.
Will I get the real drug or a placebo?
It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
How often will I need to visit the study site?
Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
Can I leave the trial if I change my mind?
Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
Will travel or parking be reimbursed?
Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
Can my spouse or care partner come with me to visits?
In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.

Related Reading

View on ClinicalTrials.gov